Gilead Wins U.S. Approval for More Convenient Hepatitis C Drug
Alert: HALISTER Source: BN (Bloomberg News)
Tickers GILD US (Gilead Sciences Inc) MVIRB SS (Medivir AB)
Topics Viral Hepatitis Cancers
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283